Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 28, 2026

Samoan Community Leaders, Environmental Advocates Call on Coca-Cola’s Largest Bottler to Keep Plastic out of the Pacific and Bring Back Reusable Packaging

View original at finance.yahoo.com
Samoan Community Leaders, Environmental Advocates Call on Coca-Cola’s Largest Bottler to Keep Plastic out of the Pacific and Bring Back Reusable Packaging Oceana, Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • CCEP is Coca-Cola's largest bottler by revenue and operates across 31 global markets including Western Europe, Indonesia, the Philippines, Australia, New Zealand, and the Pacific Islands.

    60% confidence
  • Imports of plastic bottles to Samoa more than doubled between 2020 and 2025, and Coca-Cola products account for about one-third of beverage bottle waste in the country.

    60% confidence
  • Due to limited recycling capacity in Samoa, most plastic waste ends up littered, illegally dumped, incinerated, or landfilled, with consequences visible on land, beaches, and in the water.

    60% confidence
  • Coca-Cola should move back to reusable bottles like glass in Samoa and become a leader in the transition away from plastics.

    60% confidence
  • In 2021, Coca-Cola stopped bottling its products in reusable glass bottles in Samoa and now imports large quantities of single-use plastic bottles from Fiji and New Zealand.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com